Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study.
To investigate the intra-cameral level of ganciclovir following topical application of ganciclovir gel, 0.15% for cytomegalovirus (CMV) anterior segment infection.Non-randomized, prospective, interventional clinical study.Patients with active CMV anterior segment infection seen at Singapore National...
Main Authors: | Samanthila Waduthantri, Lei Zhou, Soon-Phaik Chee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5788360?pdf=render |
Similar Items
-
Uso de ganciclovir 0,15% gel para tratamento de ceratoconjuntivite adenoviral
by: Simone Tiemi Yabiku, et al. -
Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications
by: Chou TY, et al.
Published: (2014-08-01) -
Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results
by: Yu-Chun Cheng, et al.
Published: (2021-02-01) -
Aqueous cytokine changes associated with Posner-Schlossman syndrome with and without human cytomegalovirus.
by: Jing Li, et al.
Published: (2012-01-01) -
Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation
by: Laurent Papazian, et al.
Published: (2021-02-01)